Log in

Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Interleukin-17A plays a role in tissue inflammation by inducing release of proinflammatory and neutrophil-mobilizing cytokines. We investigated the association between ulcerative colitis (UC) and polymorphisms of IL17A, rs2275913 (−197 G > A), and rs3748067 (*1249 C > T). The study was performed in 475 healthy subjects (controls) and 202 with UC (UC cases), including 113 controls and 64 UC cases from previous study. We employed the multiplex PCR-SSCP method to detect gene polymorphisms. The minor allele frequency of rs2275913 was significantly higher but that of rs3748067 was significantly lower in UC cases than controls. The rs2275913 minor homozygote (AA) had an increased risk of the development of UC, whereas rs3748067 minor carrier (CT + TT) had decreased risks for the development of UC. When compared with LR group (rs2275913 GG + GA with rs3748067 CT + TT), HR group (rs2275913 AA with rs3748067 CC) had a more increased risk of the development of UC (OR, 3.38; p = 0.0007). The polymorphisms of IL17A were associated with the noncontinuous and pancolitis phenotypes of UC. Our results suggest that IL17A polymorphisms (both rs2275913 and rs3748067) influence the susceptibility to and pathophysiological features of UC, coordinately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417–429

    Article  PubMed  CAS  Google Scholar 

  2. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F et al (2003) Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 100:3455–3460

    Article  PubMed  CAS  Google Scholar 

  3. Head KA, Jurenka JS (2003) Inflammatory bowel disease part I: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 8:247–283

    PubMed  Google Scholar 

  4. Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J (2006) Current concept on the pathogenesis of infl ammatory boweldisease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take “toll”? World J Gastroenterol 12:1829–1841

    PubMed  CAS  Google Scholar 

  5. Blumberg RS, Strober W (2001) Prospects for research in inflammatory bowel diseases. JAMA 285:643–647

    Article  PubMed  CAS  Google Scholar 

  6. Newman B, Siminovitch KA (2005) Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 21:401–407

    PubMed  Google Scholar 

  7. Tanaka M, Kazuma K (2005) Ulcerative colitis: factors affecting difficulties of life and psychological well being of patients in remission. J Clin Nurs 14:65–73

    Article  PubMed  Google Scholar 

  8. Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H et al (2007) Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis. J Gastroenterol Hepatol 22:925–929

    Article  PubMed  CAS  Google Scholar 

  9. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y et al (2008) The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 28:44–49

    Article  PubMed  CAS  Google Scholar 

  10. Shiroeda H, Tahara T, Nakamura M, Shibata T, Nomura T, Yamada H et al (2010) Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 51:173–177

    Article  PubMed  CAS  Google Scholar 

  11. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D et al (2011) Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis. J Clin Immunol 31:69–73

    Article  PubMed  CAS  Google Scholar 

  12. Rutitzky LI, Lopes da Rosa JR, Stadecker MJ (2005) Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol 175:3920–3926

    PubMed  CAS  Google Scholar 

  13. Aggarwal S, Ghilardi N, **e MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914

    Article  PubMed  CAS  Google Scholar 

  14. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476

    Article  PubMed  CAS  Google Scholar 

  15. Fu**o S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y et al (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52:65–70

    Article  PubMed  CAS  Google Scholar 

  16. Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B (2003) Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 38:180–185

    Article  PubMed  CAS  Google Scholar 

  17. Zhang Z, Hinrichs DJ, Lu H, Chen H, Zhong W, Kolls JK (2007) After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 7:409–416

    Article  PubMed  Google Scholar 

  18. Shibata T, Tahara T, Hirata I, Arisawa T (2009) Genetic polymorphism of interleukin-17A and -17F genes in gastric carcinogenesis. Hum Immunol 70:547–551

    Article  PubMed  CAS  Google Scholar 

  19. Nordang GBN, Viken MK, Hollis-Moffatt JE, Merriman TR, Forre OT, Helgetveit K et al (2009) Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology 48:367–370

    Article  PubMed  CAS  Google Scholar 

  20. Wu X, Zeng Z, Chen B, Yu J, Xue L, Hao Y et al (2010) Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 127:86–92

    Article  PubMed  CAS  Google Scholar 

  21. Chen J, Deng Y, Zhao J, Luo Z, Peng W, Yang J et al (2010) The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis. J Clin Immunol 30:539–545

    Article  PubMed  CAS  Google Scholar 

  22. Mishra PJ, Bertino JR (2009) MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 10:399–416

    Article  PubMed  CAS  Google Scholar 

  23. Podolsky DK (1991) Inflammatory bowel disease 2. N Engl J Med 325:928–937

    Article  PubMed  CAS  Google Scholar 

  24. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y et al (2007) The relationship between Helicobacter Pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis. Int J Mol Med 19:143–148

    PubMed  CAS  Google Scholar 

  25. O’Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y et al (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10:603–609

    Article  PubMed  Google Scholar 

  26. Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28:454–467

    Article  PubMed  CAS  Google Scholar 

  27. Sethupathy P, Collins FS (2008) MicroRNA target site polymorphisms and human disease. Trends Genet 24:489–497

    Article  PubMed  CAS  Google Scholar 

  28. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39:1278–1284

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was partially supported by Grant for Specially Promoted Research from Kanazawa Medical University (AR2012-07).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomiyasu Arisawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayashi, R., Tahara, T., Shiroeda, H. et al. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clin Exp Med 13, 239–244 (2013). https://doi.org/10.1007/s10238-012-0206-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-012-0206-5

Keywords

Navigation